Determination of 1,3-ß-D-glucan in the peritoneal fluid for the diagnosis of intra-abdominal candidiasis in critically ill patients: a pilot study.
Fiche publication
Date publication
juillet 2018
Journal
Minerva anestesiologica
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ALBUISSON Eliane
Tous les auteurs :
Novy E, Laithier FX, Machouart MC, Albuisson E, Guerci P, Losser MR
Lien Pubmed
Résumé
Decision to start an anti-fungal therapy in intra-abdominal candidiasis (IAC) is complex. Yeast culture, considered the gold standard, suffers from a delayed response time and exposes the patient to delayed introduction of anti-fungal therapy. We sought to evaluate the performance and feasibility of measuring 1,3-Beta-D-Glucan (1,3BDG) in the peritoneal fluid (PF) for the diagnosis of IAC.
Référence
Minerva Anestesiol. 2018 Jul 9;: